Please assess the completion status of the following clinical trial:

Trial Title: Actos Now for Prevention of Diabetes (ACT NOW)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women~* All ethnic groups~* 18 years of age and older~* Impaired glucose tolerance by glucose tolerance test (fasting glucose 95-125 mg/dl and 2 hr glucose of 140-199 mg/dl)~* At least one of the following:~  * One or more components of the insulin resistance syndrome (HDL \< 40 mg/dl in females and \<35 mg/dl in males, fasting triglycerides \> 150 mg/dl, blood pressure \> 135/85 mmHg, BMI \> 24 kg/m2, waist circumference \> 102 cm in men and \> 88 cm in women)~ * One or more first degree relatives with type 2 diabetes~ * History of gestational diabetes~ * Polycystic ovarian disease~ * Minority ethnic background (Mexican American, African American, Asian and Pacific Islanders, Native American)~Exclusion Criteria:~* Type 2 diabetes~* Previously treated with thiazolidinediones (ever) or metformin (within one year)~* Previously treated with a sulfonylurea, a meglitinide, an alpha glucosidase inhibitor for more than a week within last year or within the 3 months prior to randomization~* Previously treated with insulin (other than during pregnancy) for more than one week within the last year or within the 3 months prior to randomization~* Cardiovascular disease~* Hospitalization for treatment of heart disease or stroke in past 6 months~* New York Heart Association Functional Class \> 2~* Left bundle branch block or third degree AV block~* Aortic stenosis~* SBP \> 180 mmHg or DBP \> 105 mmHg~* Renal disease~* Anemia~* Hepatitis~* GI diseases (pancreatitis, inflammatory bowel disease)~* Recent or significant abdominal surgery~* Advanced pulmonary disease~* Chronic infections~* Weight loss \> 10% in past 6 months~* Pregnancy and childbearing~* Major psychiatric disorders~* Excessive alcohol intake~* Thiazide use \> 25 mg per day~* Non-selective beta blockers~* Niacin~* Systemic glucocorticoids~* Weight loss or weight gain medication~* Thyroid disease-suboptimally treated~* Active endocrine diseases (Cushing's, acromegaly)~* Plasma triglycerides over 400 mg/dl (despite treatment)~* History bladder cancer~* Hematuria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo tablet similar to pioglitazone tablet
- Pioglitazone (Type: ACTIVE_COMPARATOR): Pioglitazone tablet similar to placebo tablet

Based on this trial design, predict the completion outcome and termination type (if applicable).